NANOTEC and Pharmacy Council of Thailand Hold 4th Training Course to Strengthen Pharmacists’ Skills in Medication Management and Chronic Kidney Disease Care

The National Nanotechnology Center (NANOTEC), under the National Science and Technology Development Agency (NSTDA), in collaboration with the Pharmacy Council of Thailand, organized the 4th training course on “Practical Pharmacists in Medication Management for Chronic Kidney Disease” on November 14, 2026, at Centara Hotel Hat Yai, Songkhla. The training aimed to strengthen pharmacists’ knowledge and practical skills in caring for patients with chronic kidney disease (CKD), covering risk assessment, screening, medication management, and patient counseling to help slow kidney disease progression.

The training focused on key knowledge of chronic kidney disease and appropriate approaches to patient care. Experts shared their knowledge and experience on risk screening, patient monitoring, and appropriate medication use. These sessions aimed to equip pharmacists with knowledge that can be applied in their professional practice and enable them to provide effective health advice to the public.

One of the key topics was “The Use of an Innovative Urine Microalbumin Screening Test Kit.” The session introduced the innovation and its application in screening for chronic kidney disease risk, helping pharmacists understand the underlying principles and how the technology can be incorporated into healthcare services. Urine microalbumin testing provides important information for assessing kidney disease risk and monitoring potential kidney abnormalities.

The urine microalbumin screening test kit is part of NSTDA’s efforts to translate research and development outcomes into practical applications. The innovation aims to support wider access to kidney health screening technologies and improve opportunities for early identification of potential risks. Early screening plays an important role in health assessment, patient monitoring, and referral of individuals at risk to appropriate healthcare services.

The training also covered “The Role of Pharmacists in Counseling Patients to Slow Kidney Disease Progression.” The session highlighted the importance of pharmacists in providing advice on medication use, health management, and lifestyle modifications related to kidney health. These skills help pharmacists provide ongoing support to patients with chronic kidney disease and make professional pharmaceutical advice more accessible to the public.

This training course reflects the collaboration between NANOTEC, NSTDA, and the Pharmacy Council of Thailand in strengthening pharmacists’ professional capabilities and promoting the application of scientific knowledge and technology in healthcare. It also supports greater access to innovative kidney disease screening technologies, creating more opportunities for early kidney health assessment and care among the Thai population.

Share :

Scroll to Top